Skip to main content
Home

Navegación principal

  • About us
  • Services
  • News
  • Publications
  • Licenses
  • es
  • en

Menú de cuenta de usuario

  • Log in
Menu

Navegación principal

  • About us
  • Services
  • News
  • Publications
  • Licenses

CimBioLab

We are a laboratory focused on the development, validation, transfer, and execution of routine bioassays in pharma & biotech industries. We have both an in vitro and in vivo testing platform to evaluate your products according their MoA.

To learn more about our expertise areas, select "About us" in the main menu.

Colaboration_CIM_VN
Technology Transfer and Analytical Method Validation for Erythropoietin at the NICVB of Vietnam
Technology Transfer and Analytical Method Validation for Erythropoietin at the NICVB of Vietnam

Services

0 1
Immunoassay
0 2
Cell-based assays
0 3
Assays with animals
See more

Publications

Validation of a flow cytometry-based assay for monitoring complement-dependent cytotoxicity of an anti-CD20 biosimilar candidate antibody
18/03/2014

 

Abstract

Appropriate validation of any bioassay to be used in the characterization of biological products is critical. In this study, we report a validation study of a flow cytometry-…

Validation of a Flow Cytometry Based Binding Assay for Evaluation of Monoclonal Antibody Recognizing EGF Receptor
03/07/2011

 

Abstract

An ideal test used to characterize a product must be appropriate for the measurement of product quality, manufacturing consistency, product stability, and comparability studies. Flow cytometry has been…

Phenotypic heterogeneity in the NCI-H125 cell line affects biological activity using the epidermal growth factor receptor as target
08/09/2012

 

Abstract

We evaluated the influence of some morphological changes of the NCI-H125 cell line in surface expression of the epidermal growth factor receptor (EGFR) and their impact on some…

Binding Properties and Biological Activity of a Novel Therapeutic Monoclonal Antibody Directed toward HER2 Antigen
29/12/2020

 

Abstract

Several biosimilars for Herceptin® (trastuzumab) and other innovator monoclonal antibodies (mAbs) against HER2 molecule have been developed and approved in the last years. Here, it…

See more

Contact Us

Leave us a message

Center of Molecular Immunology (CIM), 15th Avenue, 216th Street and 222nd Street, Siboney, Playa, Havana, 19340, Cuba
(+53) 72714335
cim@cim.sld.cu

Redes sociales

  • Facebook
  • Youtube
Image
logo-footer

Last update

Wednesday, April 8, 2026 - 09:24

Links of Interest

CECMED
BIOCUBAFARMA
MINSAP
Center of Molecular Immunology

Support Links

  • Privacy Policies
  • Sitemap
  • Terms and Conditions of Use

Developed by the UCI. All rights reserved. 2025